ATP5O

ATP5O Full Name

ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit

ATP5O Introduction

ATP5O, historically and widely known as the oligomycin sensitivity-conferring protein (OSCP), is an indispensable structural and regulatory subunit of the mitochondrial F1Fo-ATP synthase (Complex V). Situated precisely at the functional interface of this massive molecular motor, ATP5O is a key component of the peripheral stalk. Its primary biological role is to physically and mechanically couple the membrane-embedded Fo proton channel to the soluble F1 catalytic core. By acting as a rigid stator, ATP5O holds the F1 head in place against the torque generated by the central rotor. This structural coupling is absolutely essential for transducing the electrochemical proton gradient across the inner mitochondrial membrane into the mechanical energy required to synthesize ATP. Beyond its structural duties, ATP5O functions as a dynamic metabolic sensor. It interacts with cyclophilin D (CypD) to modulate the mitochondrial permeability transition pore (mPTP) and is regulated by SIRT3-mediated deacetylation, allowing mitochondria to adapt to varying oxidative stress and energy demands.

Figure 1. ATP synthase structure and mechanism of mPTP opening. (Source: Bonora M, et al. 2022)

Clinically, the structural disruption or aberrant expression of ATP5O is robustly linked to devastating neurodegenerative and oncological pathologies. In the context of Alzheimer's disease (AD), ATP5O represents a critical locus of mitochondrial vulnerability. High-resolution studies reveal that toxic amyloid-beta (Aβ) specifically binds to the OSCP subunit in the brains of AD patients. This pathological interaction depletes OSCP levels, uncouples the ATP synthase complex, and fundamentally crashes mitochondrial bioenergetics. The resulting severe energy deficit and massive surge in reactive oxygen species (ROS) directly drive synaptic degeneration and cognitive decline. Conversely, in the field of oncology, ATP5O is frequently hijacked to support the extreme metabolic demands of malignant cells. As tumors undergo metabolic reprogramming, many heavily rely on upregulated oxidative phosphorylation to fuel rapid growth. Recent proteomic analyses have identified ATP5O as a novel, independent prognostic biomarker in aggressive prostate cancer. In these malignancies, elevated expression of ATP5O directly correlates with a higher risk of biochemical recurrence and significantly poorer overall survival outcomes. Whether acting as an Achilles' heel in neurodegeneration or a metabolic driver in cancer, ATP5O remains a highly compelling target for precision medicine.

Alternate Names for ATP5O

ATP5O; ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit; ATP synthase subunit O, mitochondrial; ATPO; oligomycin sensitivity conferring protein; OSCP; human ATP synthase OSCP subunit; oligomycin sensitivity conferral protein;

• 1. Bonora M, et al. Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol. 2022 Apr;23(4):266-285.
  2. Beck SJ, et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease. Nat Commun. 2016 May 6;7:11483.